L
LENSAR Inc (LNSR)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
$5.29
+0.29 (+5.80%)
Market Cap: $61.47M
Last updated: Nov 17, 2026 at 11:03 AM ET
LENSAR Inc (LNSR) Valuation Multiples
LENSAR (LNSR) trades at 1.1x sales and 5.9x book value. Its P/S of 1.1x is below its 5-year median of 1.3x.
Current Multiples
Its enterprise value is 2.0x its EBITDA.
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | N/A |
| Price to sales | 1.1x |
| Price to book | 5.9x |
| EV/EBITDA | 2.0x |
| PEG | N/A |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 1.1x | 1.3x | N/A |
| P/B | 5.9x | 1.4x | N/A |
Valuation History
Over the 6 year ends shown, its P/S ranged from 0.9x in 2022 to 2.4x in 2020.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $11.63 | 2.4x | N/A |
| 2024 | $8.94 | 1.9x | 21.4x |
| 2023 | $3.51 | 0.9x | 1.2x |
| 2022 | $2.96 | 0.9x | 0.7x |
| 2021 | $5.99 | 1.6x | 1.0x |
| 2020 | $7.25 | 2.4x | 0.9x |
Frequently Asked Questions About LNSR
What is LNSR's price to sales ratio?
LENSAR has a price to sales ratio of 1.1x.
LNSR pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors